What, if Any, Role Is There for BRAF-Targeted Therapy in BRAF-Mutant Melanoma?

被引:4
|
作者
Sullivan, Ryan J. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
[2] Massachusetts Gen Hosp, Canc Ctr, 55 Fruit St, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
STAGE-IV MELANOMA; MEK INHIBITION; DOUBLE-BLIND; IMPROVED SURVIVAL; MULTICENTER; VEMURAFENIB; DABRAFENIB; PLACEBO; PEMBROLIZUMAB; COBIMETINIB;
D O I
10.1200/JCO.22.01066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4161 / +
页数:6
相关论文
共 50 条
  • [1] BRAF-Targeted Therapy in the Treatment of BRAF-Mutant High-Grade Gliomas in Adults
    Johanns, Tanner M.
    Ansstas, George
    Dahiya, Sonika
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (04): : 451 - 454
  • [2] Refining Targeted Therapy Opportunities for BRAF-Mutant Melanoma
    Jenkins, Russell W.
    Barbie, David A.
    [J]. CANCER DISCOVERY, 2017, 7 (08) : 799 - 801
  • [3] Resistance to BRAF-targeted therapy in melanoma
    Sullivan, Ryan J.
    Flaherty, Keith T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1297 - 1304
  • [4] DREAMseq of therapy for BRAF-mutant melanoma
    Killock, David
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (01) : 1 - 1
  • [5] DREAMseq of therapy for BRAF-mutant melanoma
    David Killock
    [J]. Nature Reviews Clinical Oncology, 2023, 20 : 1 - 1
  • [6] The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era
    Vito Vanella
    Lucia Festino
    Claudia Trojaniello
    Maria Grazia Vitale
    Antonio Sorrentino
    Miriam Paone
    Paolo A. Ascierto
    [J]. Current Oncology Reports, 2019, 21
  • [7] The Role of BPTF in Melanoma Progression and in Response to BRAF-Targeted Therapy
    Dar, Altaf A.
    Nosrati, Mehdi
    Bezrookove, Vladimir
    de Semir, David
    Majid, Shahana
    Thummala, Suresh
    Sun, Vera
    Tong, Schuyler
    Leong, Stanley P. L.
    Minor, David
    Billings, Paul R.
    Soroceanu, Liliana
    Debs, Robert
    Miller, James R., III
    Sagebiel, Richard W.
    Kashani-Sabet, Mohammed
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (05)
  • [8] The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era
    Vanella, Vito
    Festino, Lucia
    Trojaniello, Claudia
    Vitale, Maria Grazia
    Sorrentino, Antonio
    Paone, Miriam
    Ascierto, Paolo A.
    [J]. CURRENT ONCOLOGY REPORTS, 2019, 21 (09)
  • [9] BRAF-targeted therapy and immune responses to melanoma
    Ngiow, Shin Foong
    Knight, Deborah A.
    Ribas, Antoni
    McArthur, Grant A.
    Smyth, Mark J.
    [J]. ONCOIMMUNOLOGY, 2013, 2 (06)
  • [10] Inhibition of BRAF and MEK in BRAF-mutant melanoma
    Smalley, Keiran S. M.
    Sondak, Vernon K.
    [J]. LANCET, 2015, 386 (9992): : 410 - 412